<DOC>
	<DOCNO>NCT01025817</DOCNO>
	<brief_summary>The purpose phase 3b study compare safety efficacy everolimus low dose tacrolimus mycophenolate mofetil standard dose tacrolimus kidney transplant recipient .</brief_summary>
	<brief_title>Non-inferiority Study Safety Efficacy Everolimus With Low Dose Tacrolimus Mycophenolate Mofetil With Standard Dose Tacrolimus Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Inclusion criterion : Male female renal recipient 1870 year age undergoing kidney transplantation , either primary retransplant ; Recipient cadaveric , decease donor ( include expand criterion donor organ decease donor organ cardiac death ) , live unrelated nonHLA identical living relate donor kidney ; Graft must functional ( produce great equal 100 ml urine within 24 hour transplantation ) time randomization . Exclusion criterion : Donor organ cold ischemic time &gt; 30 hour ; Males females produce less 100 ml urine first 24 hour posttransplantation ; Males females recipient ABO incompatible transplant , T cell , B cell crossmatch positive transplant ; Males females severe total hypercholesterolemia total hypertriglyceridemia ( Patients lipid lower treatment control hyperlipidemia acceptable ) ; Males females surgical medical condition , severe diarrhea , active peptic ulcer disease , uncontrolled diabetes mellitus , opinion investigator , might alter absorption , distribution , metabolism and/or excretion study medication . Other protocol relate inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Kidney transplant</keyword>
	<keyword>renal transplant</keyword>
	<keyword>immunosuppression</keyword>
	<keyword>mycophenolate mofetil</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>everolimus</keyword>
</DOC>